Nigeria’s Bet on Beating Drug-Resistant Malaria
In Africa's fastest growing city, antimalarial resistance is mounting. Can the country slow its advance?
National corporate funding for NOVA is provided by Draper. Major funding for NOVA is provided by the David H. Koch Fund for Science, the NOVA Science Trust, the Corporation for Public Broadcasting, and PBS viewers.